Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
The current price of Abbott Laboratories in the market is 84.39 US$, with a 24-hour trading volume of 730.26M US$. The asset's market cap is 147B US$, after moving 0.06% in the last day.
Tokenized Abbott Laboratories is trading at 84.61 US$, with a tokenized market cap of 11.98M US$ and a 24-hour trading volume of 1.72M US$. The tokenized asset has moved 2.89% in the past 24 hours.